Skip to main content

우홍균 교수

Hong-Gyun Wu

서울대학교 방사선종양학과 · 의학

연구실 소개

우홍균 교수의 연구실은 난소암, 갑상선암, 흉부암 및 두경부암을 중심으로 암의 분자표적치료와 면역치료의 예측 마커를 규명하는 데 주력하고 있습니다. 특히 PD-L1 발현의 동적 변화와 화학요법 이후의 면역조절 메커니즘을 분석하여 치료 반응을 예측하고자 하며, 방사선 치료의 정밀도 향상과 부작용 최소화를 위한 최신 방사선 옹호 기술(예: IMRT, VMAT, MRI 기반 방사선 치료)의 계획 품질 평가도 수행하고 있습니다. 이와 더불어, 희귀암인 갑상선암의 아구성형 및 분화형 암의 치료 전략 수립에도 기여하고 있습니다.

PD-L1 발현면역치료 예측 마커방사선 치료 최적화SABR암 치료 반응 예측

연구 현황

논문 수
165
총 인용 수
1,951
최근 5년 논문
17
주요 분야
의학

연구 성과 추이

표시된 성과는 수집된 데이터 기준으로 산출되며, 일부 차이가 있을 수 있습니다.

5개년 연도별 논문 게재 수
17총합
2021
2022
2023
2024
2025
5개년 연도별 피인용 수
35총합
20212022202320242025

주요 논문

15
1
논문|인용수 147·2016
PD-L1 expression is associated with epithelial-mesenchymal transition in head and neck squamous cell carcinoma
Chan-Young Ock, Sehui Kim, Bhumsuk Keam, Miso Kim, Tae Min Kim, Jin-Ho Kim, Yoon Kyung Jeon, Ju‐Seog Lee, Seong Keun Kwon, J. Hun Hah, Tack‐Kyun Kwon, Dong‐Wan Kim
SJR Q2OncotargetOA

// Chan-Young Ock 1, * , Sehui Kim 2, * , Bhumsuk Keam 1, 3 , Miso Kim 1 , Tae Min Kim 1, 3 , Jin-Ho Kim 4 , Yoon Kyung Jeon 2 , Ju-Seog Lee 5 , Seong Keun Kwon 6 , J. Hun Hah 6 , Tack-Kyun Kwon 6 , Dong-Wan Kim 1, 3 , Hong-Gyun Wu 4 , Myung-Whun Sung 6 , Dae Seog Heo 1, 3 1 Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea 2 Department of Pathology, Seoul National University Hospital Seoul, Korea 3 Cancer Research Institute, Seoul National University College of M

OncologyMedicine
2
논문|인용수 86·2017
Changes in programmed death-ligand 1 expression during cisplatin treatment in patients with head and neck squamous cell carcinoma
Chan-Young Ock, Sehui Kim, Bhumsuk Keam, Soyeon Kim, Yong‐Oon Ahn, Eun‐Jae Chung, Jin-Ho Kim, Tae Min Kim, Seong Keun Kwon, Yoon Kyung Jeon, Kyeong Chun Jung, Dong‐Wan Kim
SJR Q2OncotargetOA

Programmed death-ligand 1 (PD-L1) expression is regarded as a predictive marker for anti-PD-1/PD-L1 therapy. The purpose of study was to explore the changes in PD-L1 expression in head and neck squamous cell carcinoma (HNSCC) during treatment. Paired HNSCC tissues prior to and after cisplatin-based treatment were evaluated to determine PD-L1 protein expression by immunohistochemistry. Among the 35 HNSCC patient samples, PD-L1 expression status changed after treatment in 37.1% (13/35) of samples.

OncologyMedicine
3
논문|인용수 86·2017
Chemoradiation-Induced Alteration of Programmed Death-Ligand 1 and CD8+ Tumor-Infiltrating Lymphocytes Identified Patients With Poor Prognosis in Rectal Cancer: A Matched Comparison Analysis
Yu Jin Lim, Jaemoon Koh, Sehui Kim, Sang-Rok Jeon, Eui Kyu Chie, Kyubo Kim, Gyeong Hoon Kang, Sae‐Won Han, Tae‐You Kim, Seung‐Yong Jeong, Kyu Joo Park, Hong-Gyun Wu
SJR Q1International Journal of Radiation Oncology*Biology*Physics
OncologyMedicine
4
논문|인용수 81·2015
Changes of Clinicopathologic Characteristics and Survival Outcomes of Anaplastic and Poorly Differentiated Thyroid Carcinoma
Doh Young Lee, Jae‐Kyung Won, Se‐Hoon Lee, Do Joon Park, Kyeong Cheon Jung, Myung‐Whun Sung, Hong-Gyun Wu, Kwang Hyun Kim, Young Joo Park, J. Hun Hah
SJR Q1Thyroid

The choice of treatment of ATC and PDTC could be modified according to resectability and lymphatic invasion of the cancer.

Endocrinology, Diabetes and MetabolismMedicine
5
리뷰|인용수 59·2018
Intensity-modulated radiotherapy versus three-dimensional conformal radiotherapy in rectal cancer treated with neoadjuvant concurrent chemoradiation: a meta-analysis and pooled-analysis of acute toxicity
Chan Woo Wee, Hyun‐Cheol Kang, Hong-Gyun Wu, Eui Kyu Chie, Noorie Choi, Jong Min Park, Jung-In Kim, Chun‐Ming Huang, Jaw‐Yuan Wang, Shu Ng, Karyn A. Goodman
SJR Q2Japanese Journal of Clinical OncologyOA

BACKGROUND: To compare the acute gastrointestinal (GI) and genitourinary (GU) toxicity profiles between intensity-modulated radiotherapy (IMRT) and three-dimensional conformal radiotherapy (3DCRT) in rectal cancer patients treated with neoadjuvant chemoradiation (NCRT) using meta-analysis and pooled-analysis from published articles. METHODS: Literature search was performed in PubMed and EMBASE from inception to March 2017. The odd ratios (ORs) were calculated and random effects model was used fo

OncologyMedicine
6
논문|인용수 53·2002
High cyclooxygenase-2 expression is related with distant metastasis in cervical cancer treated with radiotherapy
Hak Jae Kim, Hong-Gyun Wu, In Ae Park, Sung Whan Ha
SJR Q1International Journal of Radiation Oncology*Biology*Physics
PharmacologyMedicine
7
리뷰|인용수 53·2016
IMRT vs. 2D-radiotherapy or 3D-conformal radiotherapy of nasopharyngeal carcinoma
Sung Ho Moon, Kwan Ho Cho, Chang Geol Lee, Ki Chang Keum, Yeon‐Sil Kim, Hong-Gyun Wu, Jin Ho Kim, Yong Chan Ahn, Dongryul Oh, Jong Hoon Lee
SJR Q2Strahlentherapie und OnkologieOA
OtorhinolaryngologyMedicine
8
리뷰|인용수 52·2016
Survival Impact of Adjuvant Radiation Therapy in Masaoka Stage II to IV Thymomas: A Systematic Review and Meta-analysis
Yu Jin Lim, Eunji Kim, Hak Jae Kim, Hong-Gyun Wu, Jinchun Yan, Qin Liu, Shilpen Patel
SJR Q1International Journal of Radiation Oncology*Biology*Physics
NeurologyMedicine
9
논문|인용수 52·2017
Air–electron stream interactions during magnetic resonance IGRT
Jong Min Park, Kyung Hwan Shin, Jung-In Kim, So Yeon Park, Seung Hyuck Jeon, Noorie Choi, Jin Ho Kim, Hong-Gyun Wu
SJR Q2Strahlentherapie und Onkologie
RadiationPhysics and Astronomy
10
논문|인용수 52·2019
Comparison of treatment plans between IMRT with MR-linac and VMAT for lung SABR
Jong Min Park, Hong-Gyun Wu, Hak Jae Kim, Chang Heon Choi, Jung-In Kim
SJR Q1Radiation OncologyOA

The aim of this study was to compare the plan quality of magnetic-resonance image-based intensity modulated radiation therapy (MRI-based-IMRT) with the MRIdian Linac system to that of volumetric modulated arc therapy (VMAT) with the TrueBeam STx system for lung stereotactic ablative radiotherapy (SABR). A total of 22 patients with tumors located in the lower lobe were retrospectively selected for the study. For each patient, both the MRI-based-IMRT and VMAT plans were generated using an identica

RadiationPhysics and Astronomy
11
논문|인용수 48·2011
Postoperative Radiotherapy for Completely Resected Stage II or III Thymoma
Ji Hyun Chang, Hak Jae Kim, Hong-Gyun Wu, Joo Hyun Kim, Young Tae Kim
SJR Q1Journal of Thoracic OncologyOA
NeurologyMedicine
12
논문|인용수 44·2009
LIN28B confers radio-resistance through the posttranscriptional control of KRAS
정선혜, 우홍균, Woong-Yang Park
http://kmbase.medric.or.kr/Main.aspx?d=KMBASE&m=VIEW&i=0620920090410120912

To screen the differentially expressed microRNAs related to radio-resistance, we compared the microRNA profiles of lung cancer cells with different responses to ionizing radiation (IR). Of 328 microRNAs in microarray, 27 microRNAs were differentially expressed in NCI-H460 (H460) and NCI-H1299 (H1299) cells. Among them, let-7g was down-regulated in radio-resistant H1299 cells, and the level of let-7g was higher in radio- sensitive cells like Caski, H460, and ME180 in qRT-PCR analysis than in radi

13
논문|인용수 44·2015
Long-Term Outcome of Definitive Radiotherapy for Early Glottic Cancer: Prognostic Factors and Patterns of Local Failure
Yu Jin Lim, Hong-Gyun Wu, Tack‐Kyun Kwon, J. Hun Hah, Myung‐Whun Sung, Kwang Hyun Kim, Charn Il Park
SJR Q1Cancer Research and TreatmentOA

PURPOSE: This study evaluates the long-term results of definitive radiotherapy (RT) for early glottic cancer. Clinical and treatment factors related to local control and patterns of failure are analyzed. MATERIALS AND METHODS: We retrospectively reviewed 222 patients with T1-2N0 squamous cell carcinoma of the glottic larynx treated with definitive RT from 1981 to 2010. None of the patients received elective nodal RT or combined chemotherapy. The median total RT dose was 66 Gy. The daily fraction

OtorhinolaryngologyMedicine
14
논문|인용수 35·2006
Concurrent radiotherapy with paclitaxel/carboplatin chemotherapy as a definitive treatment for squamous cell carcinoma of the uterine cervix
Me-Yeon Lee, Hong-Gyun Wu, Kyubo Kim, Sung Whan Ha, Kim Js, In Ah Kim, Hyo-Pyo Lee
SJR Q1Gynecologic Oncology
Obstetrics and GynecologyMedicine
15
논문|인용수 29·2011
High survivin expression as a predictor of poor response to preoperative chemoradiotherapy in locally advanced rectal cancer
Kyubo Kim, Eui Kyu Chie, Hong-Gyun Wu, Sang Gyun Kim, Seung Hee Lee, Gyeong Hoon Kang, Chang Lim Hyun, Sung Whan Ha
SJR Q2International Journal of Colorectal Disease
OncologyMedicine

대표 연구 분야

OtorhinolaryngologyOncologyRadiationObstetrics and GynecologySurgeryPulmonary and Respiratory Medicine

우홍균 교수의 연구를 Nubint에서 더 깊이 살펴보세요

이 연구실의 논문을 앱에서 열어 AI와 함께 읽고, 핵심을 요약하고, 내 글에 인용하세요.